Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome

BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 ...
Drovers

FSIS Releases Updated Guidelines for Verification of U.S.-Origin Label Claims

Establishments using a U.S.-origin claim on FSIS-regulated products will need to provide access to documentation ...

Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise

Rhythm Pharma rises after early Prader-Willi trial data show reduced hunger and BMI, supporting plans for a Phase 3 study of setmelanotide.
MEAT+POULTRY

FSIS updates guidelines for US-origin label claim verification

Establishments using US-origin claims will need to demonstrate the product meets regulatory requirements, effective Jan. 1.
The Santa Barbara Independent

Pacific Pickle Works Births People’s Provisions

A major force of Provisions is the private label part of the company, which produces pickles for other brands and restaurants ...
Medical Marketing & Media

Two new Untitled Letters, multiple close-outs: Latest on FDA’s pharma ad crackdown

More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...